Protocol Specific Research Support

协议特定研究支持

• 批准号: 8340201
• 负责人: George J. Weiner
• 金额: $ 5.5万
• 依托单位: UNIVERSITY OF IOWA
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-08-19 至 2016-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8340201
• 关键词: Acetates; Adenoviruses; Apoptosis; Ascorbic Acid; Cancer Center Support Grant; Clinic; Clinical Investigator; Clinical Nursing Research; Clinical Research; Clinical Trials; Collaborations; Comprehensive Cancer Center; CpG 7909; Decitabine; Development; Disease Resistance; Dose; Epigenetic Process; Funding; Grant; HIV Protease Inhibitors; Histone Deacetylase Inhibitor; Hormone Receptor; Human; Image; Instruction; Laboratories; Link; Lymphoma; Malignant Neoplasms; Malignant neoplasm of pancreas; Metastatic Melanoma; Metastatic Prostate Cancer; Modification; Monoclonal Antibody Hu1D10; Multicenter Trials; Nelfinavir; Non-Hodgkin' s Lymphoma; Patients; Peer Review; Phase; Phase I Clinical Trials; Pilot Projects; Play; Positron-Emission Tomography; Process; Protocols documentation; Radiation; Refractory; Relapse; Research; Research Activity; Research Personnel; Research Support; Resources; Role; Safety; Scientist; Therapy Clinical Trials; Translational Research; Vaccines; Valproic Acid; Work; angiogenesis; base; bevacizumab; chemotherapy; docetaxel; gemcitabine; hormone refractory prostate cancer; innovation; malignant breast neoplasm; men; novel; novel strategies; open label; phase 1 study; response; sarcoma; temozolomide; tumor

Protocol Specific Research Protocol Specific Research for the Holden Comprehensive Cancer Center supports innovative, short-term. Pilot and Phase I cancer trials based on advances made in the laboratories of Holden Comprehensive Cancer Center scientists and concepts generated by clinical investigators. These studies are also supported by institutional funds. A rigorous selection process is in place to assure only high quality studies are supported through protocol specific research.

方案特定研究 霍尔顿综合癌症中心的方案特定研究支持创新，短期。 基于霍尔顿综合癌症中心科学家实验室取得的进展和临床研究人员产生的概念的试点和I期癌症试验。这些研究也得到了机构资金的支持。一个严格的选择过程是到位的，以确保只有高质量的研究是通过特定的研究方案的支持。